Characterizing the role of SLC3A2 in the molecular landscape and immune microenvironment across human tumors.

Front Mol Biosci · 2022 · PMC9388758 · PMID 35992269

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Overall, these in vitro studies preliminarily suggest that SLC3A2 may be significant in tumor initiation and progression.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.